Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
2020 ◽
Vol 47
(13)
◽
pp. 3047-3057
◽
2011 ◽
Vol 2011
◽
pp. 1-7
◽
2021 ◽
Vol 26
(1)
◽
pp. 10-14
2020 ◽
2014 ◽
Vol 95
(3)
◽
pp. 289-300
◽
2015 ◽
Vol 43
(5)
◽
pp. 839-851
◽